<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The double-stranded <z:chebi fb="40" ids="33697">RNA</z:chebi>-dependent kinase PKR has been described for many years as strictly a pro-apoptotic kinase </plain></SENT>
<SENT sid="1" pm="."><plain>Recent data suggest that the main purpose of this kinase is damage control and repair following stress and, if <z:hpo ids='HP_0000001'>all</z:hpo> else fails, <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Aberrant activation of PKR has been reported in numerous <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Although a subset of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> contain low levels of PKR expression and activity, elevated PKR activity and/or expression have been detected in a wide range of <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e>, from <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> disorders to <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>With the recent findings that <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> containing elevated PKR activity are highly sensitive to PKR inhibition, we explore the role of PKR in <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e>, signal transduction pathways affected by PKR, and how PKR may contribute to leukemic transformation </plain></SENT>
</text></document>